Skip to main content
. 2014 Apr 28;13(7):1625–1643. doi: 10.1074/mcp.O113.034918

Fig. 1.

Fig. 1.

Schematic representation of the RPPA workflow. Reprinted from Mueller, C. M., Liotta, L. A., and Espina, V. (2010) Reverse phase protein microarrays advance to use in clinical trials. Mol. Oncol. 4, 461–481. Copyright (2010), with permission from Elsevier.

HHS Vulnerability Disclosure